Change of Th1/Th2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection

Yu Yong-hao; Cui Nai-qiang; Fu Qiang; Li Jun

doi:10.1007/BF02836471

Your Location：

Home >

Browse articles >

Change of Th1/Th2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection

Updated：2021-08-27

- Change of Th1/Th2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection
- Chinese Journal of Integrative Medicine Vol. 11, Issue 2, Pages: 136-141(2005)
- Affiliations：
  
  1. General Hospital of Tianjin Medical University,Tianjin
  2. Nankai Hospital,China
- Author bio：
- Funds：
  
  Supported Financially by Tianjin Science and Technology Committee (No. 98113411)
- DOI：10.1007/BF02836471
  CLC：
- Published：2005，
Scan for full text
Yong-hao, Y., Nai-qiang, C., Qiang, F. et al. Change of Th1/Th2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection., Chin. J. Integr. Med. 11, 136–141 (2005). https://doi.org/10.1007/BF02836471

Yu Yong-hao, Cui Nai-qiang, Fu Qiang, et al. Change of Th1/Th2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection. [J]. Chinese Journal of Integrative Medicine 11(2):136-141(2005)
Yong-hao, Y., Nai-qiang, C., Qiang, F. et al. Change of Th1/Th2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection., Chin. J. Integr. Med. 11, 136–141 (2005). https://doi.org/10.1007/BF02836471 DOI：

Yu Yong-hao, Cui Nai-qiang, Fu Qiang, et al. Change of Th1/Th2 cytokine equilibrium in rats with severe sepsis and therapeutic effect of recombinant interleukin-12 and Shenmai injection. [J]. Chinese Journal of Integrative Medicine 11(2):136-141(2005) DOI： 10.1007/BF02836471.

摘要

Objective: To evaluate the dynamic change of Thl/Th2 cytokines in serum

peritoneal lavage fluid (PLF) and splenic macrophages (SM) in rats with severe peritonitis

and to observe the therapeutic effects of recombinant interleukin-12 (rlL-2) and Shenmai injection (SMI)

a Chinese medicinal preparation.Methods: Severe peritonitis (SP) model was induced by intraperitoneal injection of E. coli and B. frag

and mild peritonitis (MP) model was induced by cecal ligation and punching. Then the following experiments were done: (1) Survival rates of animals after every 6 hrs in the 72 hrs after modeling were recorded

serum and PLF levels of cytokines

including tumor necrosis factor-α (TNF-α)

interferon-γ (IFN-γ)

and interleukin-10 (IL-10)

6 hrs

12 hrs

24 hrs and 48 hrs after modeling were measured. (2) Model rats were treated with rIL-12 or SMI

the survival rate was recorded and serum levels of TNF-α

INF-γ

and IL-10 before and after treatment were measured

and (3) amount of these cytokines produced by SM were determined 6 hrs

12 hrs and 24 hrs after treatment. The survival rates and levels of cytokines were then compared between the groups (model group treated with rIL-12 or SMI

untreated model group

and blank group).Results: Serum and PLF levels of IFN-γ

TNF-α at all the time points in SP rats were significantly lower than those in MP rats while those of IL-10 6 hrs and 12 hrs after modeling were significantly higher in the former than that in the latter (P<0.05). IFN-γ secretion of SM in SP rats was significantly higher than that in MP rats 6 hrs after modeling (P<0. 05). Administration of rlL-12 or SMI given before modeling could improve the survival rate of the model rats (P<0.05) and cause significant increase of the serum level and SM secretion of IFN-γ.Conclusion: Imbalance in promoting/antagonizing inflammatory cytokines and Th2 response dominance appear in SP rats early at the initiating stage

and SM secretion of inflammation promoting factor also reduces. Administration in time of rIL-12 and SMI

may increase the survival rate

and its mechanism may be related with their immuno-stimulating action.

Abstract

Objective: To evaluate the dynamic change of Thl/Th2 cytokines in serum

peritoneal lavage fluid (PLF) and splenic macrophages (SM) in rats with severe peritonitis

and to observe the therapeutic effects of recombinant interleukin-12 (rlL-2) and Shenmai injection (SMI)

a Chinese medicinal preparation.Methods: Severe peritonitis (SP) model was induced by intraperitoneal injection of E. coli and B. frag

serum and PLF levels of cytokines

including tumor necrosis factor-α (TNF-α)

interferon-γ (IFN-γ)

and interleukin-10 (IL-10)

6 hrs

12 hrs

24 hrs and 48 hrs after modeling were measured. (2) Model rats were treated with rIL-12 or SMI

the survival rate was recorded and serum levels of TNF-α

INF-γ

and IL-10 before and after treatment were measured

and (3) amount of these cytokines produced by SM were determined 6 hrs

12 hrs and 24 hrs after treatment. The survival rates and levels of cytokines were then compared between the groups (model group treated with rIL-12 or SMI

untreated model group

and blank group).Results: Serum and PLF levels of IFN-γ

and SM secretion of inflammation promoting factor also reduces. Administration in time of rIL-12 and SMI

may increase the survival rate

and its mechanism may be related with their immuno-stimulating action.

关键词

sepsisimmuno-modulatory cytokineinterleukintumor necrosis factorinterferonsplenic macrophageShenmai injectionrat

Keywords

sepsisimmuno-modulatory cytokineinterleukintumor necrosis factorinterferonsplenic macrophageShenmai injectionrat

references

Kelly L, Lyons A, Soberg C, et al. Anti-interleukin-10 antibody restores burn induced defects in T-cell function. Surgery 1997; 122(2): 146–149.

Baker C, Chadry 1, Gaines H, et al. Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery 1990; 94 (4): 331–337.

Rocken M, Saurat J, Hauser C. A common precursor for CD4+ T cells producing IL-2 or IL-4. J Inmmunol 1997; 158(9): 1031–1036.

Steinhauser M, Hogaboam C, Kunkel S, et al. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defend. J Immunol 1999; 162 (4): 392–397.

Heidecke CD, Hensler T, Weighardt H, et al. Selective detects of T lymphocytes function in patients with lethal intraabdominal infections. Am J Surg 1999; 178(2): 288–294.

Decker D, Schondorf M, Bidlingmaicr F, et al. Surgical stress induces a shift in the type-l/type-2 T helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery 1996; 119(3): 316–324.

Rongione A, Kusske A, Ashley S. et al. Interleukin-10 prevents early cytokine release in severe intra-abdominal infection and sepsis. J Surg Res 1996; 76(1): 107–113.

Selzman C, Shames B, Miller S, et al. Therapeutic implications of interleukin-10 in surgical disease. Shock 1998; 10(2): 309–313.

Lyons A, Kelly J, Rodrick M, et al. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 1997; 226(3): 450–457.

Neidhardt R, Keel M, Steckholzer U, et al. Relationship of interleukin-10 plasma levels to severity of injury and clinical outcome in injured patients. J Trauma 1999; 42(7): 863–870.

Song G, Chung C, Schwacha M. et al. Splenic immune suppression in sepsis: a role for IL-10 induced changes in P38 MAPK signaling. J Surg Res 1999; 83(1): 36–44

Gennari R, Alexander J, Eaves-Pyles T. IFN-gamma decreases translocation and improves survival following transfusion and thermal injury. J Surg Res 1994; 83 (4): 530–536.

Goebel A, Kavanagh E, Lyons A, et al. Injury induces deficient interleukin-12 production, but interleukin-12 therapy alter injury restores resistance to infection. Ann Surg 2000; 231(2): 253–259.

Steinhauser M, Hogaboam C, Lukacs N, et al. Multiple roles for IL-12 in a model of acute septic peritonitis. J Immunol 1999; 162(11): 5437–5445.

Lin HY, Guo XS, Yao YM, et al. Clinical trial to verify the value of the CD14+ monocyte human leukocyte antigen DR as a marker in evaluating immunosuppression in patients with severe sepsis. Chinese Crit Care Med 2003; 15(1): 135–146.

Wei YL, Li YJ, Liu X, et al. Experimental study of protective effect of Shenmai Injection on endotoxin induced systemic inflammatory reaction syndrome and multiple organ dysfunction syndrome in mice. Chin J Integr Tradit West Med 2001; 20(1): 47–50.

FULL TEXT LINK

More>

Views

372

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Study on acupuncture parameters impacting on the acupuncture effect using cluster analysis in a rat model with middle cerebral artery occlusion

Anti-inflammatory effect of Qingwen Baidu Decoction (清瘟败毒饮) in sepsis rats

Qindan capsule (芩丹胶囊) changes adventitial collagen synthesis in spontaneously hypertensive rats

Regulation of C-type natriuretic peptides and natriuretic peptide receptor-B expression in diabetic rats renal treated by Tongluo Recipe (通络方)

Effect of wenhua juanbi recipe (温化蠲痹方) on proliferation and apoptosis of synoviocytes in rats with collagen-inducing arthritis

Related Author

No data

Related Institution

Tianjin Key Laboratory of Acupuncture and Moxibustion Science

Mathematics College of Tianjin Polytechnic University

Class II Laboratory of Acupuncture Quantity-Effect Relationship Affiliated to the State, Administration of Traditional Chinese Medicine

Critical Research Room of Encephalopathy Acupuncture Therapy

Moxibustion College of Jiangxi University of Traditional Chinese Medicine

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰